InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,691.50
(
-0.39%
)
US TECH 100
19,243.20
(
-0.47%
)
Dow Jones
41,953.69
(
-0.17%
)
Brent Oil
73.95
(
-0.50%
)
Bitcoin
63,095.79
(
0.24%
)
Post# of 2238
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

aloha2213

Send PM Follow Ignore
Followers 2
Posts 129
Boards Moderated 0
Alias Born 10/01/2000

aloha2213

Member Level

Re: dejgaard post# 2061

Thursday, 06/05/2003 7:03:33 PM

Thursday, June 05, 2003 7:03:33 PM

Post# of 2238
Hey KD

I did a little research and got somewhat confused by an article which stated

"Tomera's research also studied the accuracy of cytology, a laboratory-based urine test. Cytology correctly identified only 18 percent of the individuals with bladder cancer, missing 15 patients with the disease. Cystoscopy combined with cytology did not improve the detection rate of bladder cancer."

Is this the NMPS test? Or am I confused? What I read here does not compel me to buy the stock. Sorry if this is a dumb question. Biotech is not my forte.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up